What is TNA – Calls for HITRIplus

In HITRIplus, all five European heavy ion research centers have formed a consortium to promote the research and implementation of the clinical applications of hadron irradiation. A centerpiece of the project are almost 500 hours of transnational access (TNA) that can be awarded to researchers and clinicians.

Applicants wishing to access any facility in another country are eligible, with special focus on applicants from countries that do not dispose of a hadron accelerator themselves. Applications can be submitted anytime. This call is issued to especially attract the attention of clinicians and clinical radiobiologists.

Research TNA:

The HITRIplus consortium offers financial support for access to their heavy ion research facilities in Europe. Submit your proposal for an excellent research project in the fields of

  • radiation biology for heavy ions radiotherapy
  • medical physics of heavy ions
  • nuclear physics applied to particle therapy
  • new model systems for pre-clinical experiments with heavy ions

HITRIplus provides free of cost beamtime, travel and accommodation for investigators from other countries, giving you the unique opportunity to pursue your clinical research ideas in our world-class facilities.

Calls are open to academia, research institutes and industry world-wide. Submission of proposals is user-friendly via our online form, and is followed by rapid expert evaluation.

For any additional information, please contact Dr. Konrad Lehmann: k.lehmann@gsi.de


Clinical TNA:

We invite physicians, mainly oncologists, radiotherapists and medical physicists, to the four heavy ion treatment centers in Europe in order to join clinical research in hadron therapy through the submission of a clinical case for C-ion treatment, the comparison of treatment plans (photons, C-ions, protons), the discussion for C-ion eligibility of clinical cases or for clinical research trials in Hadrontherapy, and actively participate in the workflow of hadron treatment. We especially encourage colleagues concerned with the clinical research of:

  • Chordoma & chondrosarcoma base/spine
  • Meningiomas
  • Brain tumors (trunk)
  • ACC Salivary Glands
  • Orbit tumors including eye melanoma
  • Sinonasal carcinoma
  • Soft Tissue & bone Sarcoma (every sites)
  • Recurrent tumors (retreatment)
  • Patients with immulogical desorders

Visits of a group of 2-3 clinical researchers for up to one week are possible at a treatment facility of your choice. HITRIplus provides funding of travel and accommodation costs.

For any additional information, please contact Dr. Konrad Lehmann: k.lehmann@gsi.de





Join HITRIplus beam access video